Skip to main content

Advertisement

Articles

Page 5 of 12

  1. Authors: Shannon Gwin Mitchell, Arethusa S Kirk, Marla Oros, Jan Gryczynski, Kristi Dusek, Colleen Hosler, Robert P Schwartz, Barry S Brown, Carolina Barbosa, Laura J Dunlap, David W Lounsbury and Kevin E O'Grady

    Citation: Addiction Science & Clinical Practice 2015 10(Suppl 2):O24

    Content type: Oral presentation

    Published on:

    This article is part of a Supplement: Volume 10 Supplement 2

  2. Authors: Emily Williams, CE Achtmeyer, JP Young, KA Bradley, D Berger, MB Siegel, G Curran, EJ Ludman, GT Lapham, AHS Harris and M Forehand

    Citation: Addiction Science & Clinical Practice 2015 10(Suppl 2):P12

    Content type: Poster presentation

    Published on:

    This article is part of a Supplement: Volume 10 Supplement 2

  3. Driving under the influence (DUI) is a significant problem, and there is a pressing need to develop interventions that reduce future risk.

    Authors: Karen Chan Osilla, Susan M. Paddock, Thomas J. Leininger, Elizabeth J. D’Amico, Brett A. Ewing and Katherine E. Watkins

    Citation: Addiction Science & Clinical Practice 2015 10:18

    Content type: Research

    Published on:

  4. Homelessness, substance use, and mental disorders each have been associated with higher rates of emergency department (ED) use and hospitalization. We sought to understand the correlation between ED use, hospi...

    Authors: Adrienne Cheung, Julian M Somers, Akm Moniruzzaman, Michelle Patterson, Charles J Frankish, Michael Krausz and Anita Palepu

    Citation: Addiction Science & Clinical Practice 2015 10:17

    Content type: Research

    Published on:

  5. When opioid-agonist treatments were approved in France in 1995, opiate use disorders began to be managed and treated by general practitioners (GPs), who have since then been encouraged to treat substance use d...

    Authors: Pierre Poloméni, Claude Bronner, Fréderic Fry, Bruno Ravoninjatovo and Mélina Fatseas

    Citation: Addiction Science & Clinical Practice 2015 10:16

    Content type: Research

    Published on:

  6. Individuals with substance use disorders can receive important abstinence-specific support in 12-step groups (TSGs). However, our understanding of key factors that influence TSG participation remains limited. ...

    Authors: John-Kåre Vederhus, Sarah E. Zemore, Jostein Rise, Thomas Clausen and Magnhild Høie

    Citation: Addiction Science & Clinical Practice 2015 10:15

    Content type: Research

    Published on:

  7. Telemedicine use in addiction treatment and recovery services is limited. Yet, because it removes barriers of time and distance, telemedicine offers great potential for enhancing treatment and recovery for peo...

    Authors: Todd Molfenter, Mike Boyle, Don Holloway and Janet Zwick

    Citation: Addiction Science & Clinical Practice 2015 10:14

    Content type: Case Study

    Published on:

  8. Various hospital accreditation and quality assurance entities in the United States have approved and endorsed performance measures promoting alcohol brief intervention (BI) for hospitalized individuals who scr...

    Authors: Lauren M Broyles, Melissa E Wieland, Andrea L Confer, Monica M DiNardo, Kevin L Kraemer, Barbara H Hanusa, Ada O Youk, Adam J Gordon and Mary Ann Sevick

    Citation: Addiction Science & Clinical Practice 2015 10:13

    Content type: Study Protocol

    Published on:

  9. Although opioid-agonist therapy with methadone or buprenorphine/naloxone is currently the mainstay of medical treatment for opioid use disorder, these medications often are not well accepted or tolerated by pa...

    Authors: Keith Ahamad, MJ Milloy, Paul Nguyen, Sasha Uhlmann, Cheyenne Johnson, Todd P Korthuis, Thomas Kerr and Evan Wood

    Citation: Addiction Science & Clinical Practice 2015 10:12

    Content type: Research

    Published on:

  10. The present investigation aimed to provide an objective narrative review of the existing literature pertaining to the benefits and harms of marijuana use for the treatment of the most common medical and psycho...

    Authors: Katherine A Belendiuk, Lisa L Baldini and Marcel O Bonn-Miller

    Citation: Addiction Science & Clinical Practice 2015 10:10

    Content type: Review

    Published on:

  11. Recent designer drugs, also known as “legal highs,” include substituted cathinones (e.g., mephedrone, methylone, and methylenedioxypyrovalerone, often referred to as “bath salts”); synthetic cannabinoids (SCs;...

    Authors: Michael F Weaver, John A Hopper and Erik W Gunderson

    Citation: Addiction Science & Clinical Practice 2015 10:8

    Content type: Review

    Published on:

  12. Patient-centered models of assessment have shown considerable promise for increasing patients’ readiness for mental health treatment in general, but have not been used to facilitate patients’ engagement in sub...

    Authors: Daniel M Blonigen, Christine Timko, Theodore Jacob and Rudolf H Moos

    Citation: Addiction Science & Clinical Practice 2015 10:9

    Content type: Research

    Published on:

  13. Treating alcohol use disorders (AUD) is critical in individuals suffering from hepatitis C infection (HCV). Aside from psychosocial interventions, pharmacological treatment is effective for decreasing alcohol ...

    Authors: Alexis Thibault, Suzanne Brissette and Didier Jutras-Aswad

    Citation: Addiction Science & Clinical Practice 2015 10:6

    Content type: Review

    Published on:

  14. University students have high levels of tobacco and other drug use, yet they are unlikely to seek traditional care. Technology-based interventions are highly relevant to this population. This paper comprises a...

    Authors: Amelia Gulliver, Louise Farrer, Jade KY Chan, Robert J Tait, Kylie Bennett, Alison L Calear and Kathleen M Griffiths

    Citation: Addiction Science & Clinical Practice 2015 10:5

    Content type: Research

    Published on:

Affiliated with

Annual Journal Metrics

  • Speed
    87 days to first decision for reviewed manuscripts only
    71 days to first decision for all manuscripts
    186 days from submission to acceptance
    21 days from acceptance to publication

    Citation Impact
    1.106 - SCImago Journal Rank (SJR)
    2.91 - CiteScore

    Usage 
    237,813 Downloads
    614 Altmetric mentions

Advertisement